Bytyçi et al. recently conducted a meta-analysis that found that giving colchicine for 24 h reduced inflammatory markers (hs-CRP, IL-1, IL-6, and IL-18) in patients with unstable CAD (9). Here, IL18 is linked to coronary artery disorder.